JYPC(SZ:002198) Zheng Quan Ri Bao Wang·2026-01-07 14:11Core Viewpoint - The company, Jiaying Pharmaceutical, reported that as of December 31, 2025, the total number of holders in its combined ordinary and margin trading accounts is expected to reach 24,806 [1] Summary by Category Company Information - Jiaying Pharmaceutical has engaged with investors through an interactive platform, providing insights into its account holder projections [1] - The company anticipates a significant number of account holders by the end of 2025, indicating potential growth in investor interest and engagement [1] Industry Context - The increase in account holders may reflect broader trends in the pharmaceutical industry, where investor participation is crucial for funding and growth [1] - The company's proactive communication with investors may set a precedent for transparency and engagement within the industry [1]